Understanding and Managing Recurrent Prostate Cancer
June 17, 2019
A Diagnostic Imaging Test That May Detect and Localize Recurrent Prostate Cancer
There’s big decisions to be made for patients living with recurrent prostate cancer, from what’s next to treatment options, recurrence management, and more.
However, in the management of recurrent prostate cancer, conventional imaging (bone scans, CT, and MRI) have limitations.
Newer PET/CT imaging techniques can provide physicians and patients living with prostate cancer an opportunity to detect and localize recurrent disease at a much lower PSA level than conventional imaging.
The information provided by this type of PET/CT imaging may provide an opportunity for more personalized disease management.
Stay tuned as Dr. Jonathan K. Jay and his patient Peter Irving share the importance of knowing your options in the ongoing monitoring and management of recurrent prostate cancer.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.